RHB Group Research analyst Shekhar Jaiswal believes it is a good time for investors to buy Raffles Medical Group (RMG) shares in view of its recent share price weakness. 

“[Raffles Medical’s] valuation looks compelling, especially amidst a sustained estimated earnings growth over the forecast period,” he remarks in a Nov 19 research note.


See: 1007 Brokers Digest


To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook